KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novartis Ag (NVS) Total Non-Current Liabilities (2016 - 2025)

Historic Total Non-Current Liabilities for Novartis Ag (NVS) over the last 17 years, with Q4 2025 value amounting to $37.1 billion.

  • Novartis Ag's Total Non-Current Liabilities rose 2614.52% to $37.1 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $37.1 billion, marking a year-over-year increase of 2614.52%. This contributed to the annual value of $37.1 billion for FY2025, which is 2614.52% up from last year.
  • Novartis Ag's Total Non-Current Liabilities amounted to $37.1 billion in Q4 2025, which was up 2614.52% from $30.5 billion recorded in Q3 2025.
  • Over the past 5 years, Novartis Ag's Total Non-Current Liabilities peaked at $41.0 billion during Q1 2021, and registered a low of $25.3 billion during Q1 2024.
  • Moreover, its 5-year median value for Total Non-Current Liabilities was $30.2 billion (2025), whereas its average is $31.3 billion.
  • As far as peak fluctuations go, Novartis Ag's Total Non-Current Liabilities tumbled by 2054.71% in 2021, and later skyrocketed by 2614.52% in 2025.
  • Novartis Ag's Total Non-Current Liabilities (Quarter) stood at $33.8 billion in 2021, then decreased by 13.0% to $29.4 billion in 2022, then dropped by 8.75% to $26.8 billion in 2023, then grew by 9.79% to $29.4 billion in 2024, then rose by 26.15% to $37.1 billion in 2025.
  • Its last three reported values are $37.1 billion in Q4 2025, $30.5 billion for Q3 2025, and $30.6 billion during Q2 2025.